These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 947298)

  • 1. Effect of body temperature on cardiotoxicity of isoprenaline in rats.
    Harri MN
    Acta Pharmacol Toxicol (Copenh); 1976 Aug; 39(2):214-24. PubMed ID: 947298
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of thalidomide on isoprenaline-induced acute myocardial injury: a haemodynamic, histopathological and ultrastructural study.
    Loh HK; Sahoo KC; Kishore K; Ray R; Nag TC; Kumari S; Arya DS
    Basic Clin Pharmacol Toxicol; 2007 Apr; 100(4):233-9. PubMed ID: 17371527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Catecholamine-thyroid hormone interaction in cold-acclimated rats.
    Fregly MJ; Field FP; Katovich MJ; Barney CC
    Fed Proc; 1979 Jul; 38(8):2162-9. PubMed ID: 446768
    [No Abstract]   [Full Text] [Related]  

  • 4. Cardiotoxicity of hydralazine and minoxidil in the rat. Influence of age.
    Hanton G; Longeart L; Lodola A
    Res Commun Chem Pathol Pharmacol; 1991 Feb; 71(2):231-4. PubMed ID: 2047568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic treatment with catecholamines and the cardiovascular system.
    LeBlanc J; Vallières J; Bureau M; Labrie A; Deshaies Y; Vachon C
    Recent Adv Stud Cardiac Struct Metab; 1973; 3():527-32. PubMed ID: 4806666
    [No Abstract]   [Full Text] [Related]  

  • 6. Further observations on the cardiotoxicity of isoprenaline during hypoxia.
    McDevitt DG; Shanks RG; Swanton JG
    Br J Pharmacol; 1974 Mar; 50(3):335-44. PubMed ID: 4852115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiotoxicity of isoproterenol in experimental animals. Influence of stress, obesity, and repeated dosing.
    Balazs T
    Recent Adv Stud Cardiac Struct Metab; 1972; 1():770-8. PubMed ID: 4681502
    [No Abstract]   [Full Text] [Related]  

  • 8. Protective effect of Emblica officinalis (amla) on isoproterenol-induced cardiotoxicity in rats.
    Ojha S; Golechha M; Kumari S; Arya DS
    Toxicol Ind Health; 2012 Jun; 28(5):399-411. PubMed ID: 22033422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Captopril modifies the response of infarcted rat hearts to isoprenaline stimulation.
    van Wijngaarden J; Monnink SH; Bartels H; van Gilst WH; de Graeff PA; de Langen CD; Wesseling H
    J Cardiovasc Pharmacol; 1992 May; 19(5):741-7. PubMed ID: 1381772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of certain monoamine oxidase inhibitors on isoproterenol-induced cardiac necrosis in rats.
    Stanton HC; Schwartz A
    Proc West Pharmacol Soc; 1966; 9():6-8. PubMed ID: 4381147
    [No Abstract]   [Full Text] [Related]  

  • 11. Myocardial necroses produced by intravenous infusion of isoprenaline into rats.
    Gryglewski RJ; Kulig A; Kostka-Trabka E
    J Pharm Pharmacol; 1971 Dec; 23(12):926-30. PubMed ID: 4402017
    [No Abstract]   [Full Text] [Related]  

  • 12. Valsartan, an angiotensin II receptor blocker, attenuates cardiac dysfunction and oxidative stress in isoproterenol-induced cardiotoxicity.
    Goyal S; Bharti S; Sahoo KC; Sharma AK; Arya DS
    Cardiovasc Toxicol; 2011 Jun; 11(2):148-56. PubMed ID: 21380857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extraordinary potentiation of isoproterenol cardiotoxicity by corticoid pretreatment.
    Guideri G; Barletta MA; Lehr D
    Cardiovasc Res; 1974 Nov; 8(6):775-86. PubMed ID: 4457230
    [No Abstract]   [Full Text] [Related]  

  • 14. Beta-receptor sensitization by repeated injections of isoproterenol and by cold adaptation.
    LeBlanc J; Vallières J; Vachon C
    Am J Physiol; 1972 Apr; 222(4):1043-6. PubMed ID: 4402124
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacokinetic-pharmacodynamic modelling of S(-)-atenolol in rats: reduction of isoprenaline-induced tachycardia as a continuous pharmacodynamic endpoint.
    van Steeg TJ; Freijer J; Danhof M; de Lange EC
    Br J Pharmacol; 2007 Jun; 151(3):356-66. PubMed ID: 17420778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential venous effects of isoprenaline in conscious rats.
    Abdelrahman A; Pang CC
    Eur J Pharmacol; 1990 Nov; 190(3):321-7. PubMed ID: 2272370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effect of isoprenaline pretreatment on the cardiotoxic effect of the same drug.
    Faltová E; Mráz M; Sedivý J
    Physiol Bohemoslov; 1983; 32(4):307-17. PubMed ID: 6622555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensitivity and resistance of the myocardium to the toxicity of isoproterenol in rats.
    Balazs T; Johnson G; Joseph X; Ehrreich S; Bloom S
    Adv Exp Med Biol; 1983; 161():563-77. PubMed ID: 6869082
    [No Abstract]   [Full Text] [Related]  

  • 19. Cardiotoxicity of high doses of isoproterenol on cardiac haemodynamics and metabolism in SHR and WKY rats.
    Tisné-Versailles J; Constantin M; Lamar JC; Pourrias B
    Arch Int Pharmacodyn Ther; 1985 Jan; 273(1):142-54. PubMed ID: 3159365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening, verification, and analysis of biomarkers for drug-induced cardiac toxicity in vitro based on RTCA coupled with PCR Array technology.
    Zhang L; Xu MX; Yin QS; Zhu CY; Cheng XL; Ren YR; Zhuang PW; Zhang YJ
    Toxicol Lett; 2017 Feb; 268():17-25. PubMed ID: 28099878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.